36th Annual JPM Healthcare Conference

gtmrick
December 25, 2017
Uncategorized

In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

Preventing the flu: Researchers looking for a new approach

About

Vasomune Therapeutics 2018 © All Rights Reserved.